1. Patterns of Locoregional Relapses in Patients with Contemporarily Staged Stage III-N2 NSCLC Treated with Induction Chemotherapy and Resection: Implications for Postoperative Radiotherapy Target Volumes 
Charlotte Billiet, MD, Dirk De Ruysscher, MD, PhD, Stéphanie Peeters, MD, PhD, Herbert Decaluwé, MD, Johan Vansteenkiste, MD, PhD, Christophe Dooms, MD, PhD, Christophe M. Deroose, MD, PhD, Paul De Leyn, MD, PhD, Marc Hendrikx, MD, PhD, Paul Bulens, MD, Cécile Le Péchoux, MD, Jeroen Mebis, MD, PhD 
Journal of Thoracic Oncology 
Volume 11, Issue 9, Pages (September 2016)
DOI: /j.jtho
Copyright © 2016 International Association for the Study of Lung Cancer Terms and Conditions

2. Figure 1
Overview of locoregional relapses (LRs) per lymph node station in all patients (A) and in those with right-sided tumors (B), upper and middle right-sided tumors (C), lower right-sided tumors (D), left-sided tumors (E), upper and middle left-sided tumors (F), and lower left-sided tumors (G).
Journal of Thoracic Oncology  , DOI: ( /j.jtho )
Copyright © 2016 International Association for the Study of Lung Cancer Terms and Conditions

3. Figure 2
Overview of locoregional relapses per lymph node station in right- versus left-sided tumors in the postoperative radiation therapy (PORT) and non-PORT groups: (A) right-sided tumors in the PORT group, (B) left-sided tumors in the PORT group, (C) right-sided tumors in the non-PORT group, and (D) left-sided tumors in the non-PORT group.
Journal of Thoracic Oncology  , DOI: ( /j.jtho )
Copyright © 2016 International Association for the Study of Lung Cancer Terms and Conditions

4. Figure 3
Relapses according to the (virtual) planning target volume (PTV) and distribution of locoregional relapse (LR) outside the (virtual) PTV in the postoperative radiation therapy (PORT) group (A) and in the non-PORT group (B) per protocol.
Journal of Thoracic Oncology  , DOI: ( /j.jtho )
Copyright © 2016 International Association for the Study of Lung Cancer Terms and Conditions